Contrasting the resource-based view and competitiveness theories: How pharmaceutical firms choose to compete in Germany, Italy and the UK

Strategic Organization

Volumn 6, Issue 4, 2008, Pages 343-374

  Herrmann, Andrea M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Competitive strategies; Competitiveness theories; Pharmaceutical industry; Resource based view; Varieties of capitalism

Indexed keywords

EID: 56049101610     PISSN: 14761270     EISSN: 1741315X     Source Type: Journal    
DOI: 10.1177/1476127008096362     Document Type: Article

References (83)

1. Amable, B. (2003) The Diversity of Modern Capitalism. Oxford: Oxford University Press.
2. Andersen, E.S. (1992) 'Approaching National Systems of Innovation', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 68-92. London: Pinter.
3. Andrews, K.R. (1987) The Concept of Corporate Strategy. Homewood, IL: Irwin.
4. Barney, J.B. (1991) 'Firm Resources and Sustained Competitive Advantage', Journal of Management 17: 99-120.
5. Barney, J.B. and Clark, D.N. (2007) Resource-Based Theory: Creating and Sustaining Competitive Advantage. Oxford: Oxford University Press.
6. Bottazzi, G., Dosi, G., Lippi, M., Pammolli, F. and Riccaboni, M. (2001) 'Innovation and Corporate Growth in the Evolution of the Drug Industry', International Journal of Industrial Organization 19: 1161-87.
7. Bresser, R.K.F. (2004) 'Ressourcenbasierter Ansatz', in G. Schreyögg and A. V. Werder (eds) Handwörterbuch Unternehmensführung und Organisation, 4 th edn, pp. 1269-78. Stuttgart: Schäffel-Poeschel Verlag.
8. Casper, S. (2001) 'The Legal Framework for Corporate Governance: The Influence of Contract Law on Company Strategies in Germany and the United States', in P. A. Hall and D. W. Soskice (eds) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage, pp. 387-416. Oxford: Oxford University Press.
9. Casper, S. and Matraves, C. (2003) 'Institutional Frameworks and Innovation in the German and UK Pharmaceutical Industry', Research Policy 32: 1865-79.
10. Casper, S. and Soskice, D.W. (2004) 'Sectoral Systems of Innovation and Varieties of Capitalism: Explaining the Development of High-Technology Entrepreneurship in Europe', in F. Malerba (ed.) Sectoral Systems of Innovation, pp. 348-87. Cambridge: Cambridge University Press.
11. Casper, S. and Whitley, R. (2004) 'Managing Competences in Entrepreneurial Technology Firms: A Comparative Institutional Analysis of Germany, Sweden, and the UK', Research Policy 33: 89-106.
12. Casper, S., Lehrer, M. and Soskice, D.W. (1999) 'Can High-Technology Industries Prosper in Germany? Institutional Frameworks and the Evolution of the German Software and Biotechnology Industries', Industry and Innovation 6: 5-24.
13. Chesnais, F. (1993) 'The French National System of Innovation', in R. R. Nelson (ed.) National Innovation Systems: A Comparative Analysis, pp. 192-229. Oxford: Oxford University Press.
14. Chiesa, V. (2004) Il Cluster Biotecnologico Lombardo. Milano: Assobiotec (Federchimica).
15. Coleman, J.S. (1986) 'Social Theory, Social Research, and a Theory of Action', The American Journal of Sociology 91: 1309-35.
16. Coleman, J.S. (1990) Foundations of Social Theory. Cambridge, MA: The Belknap Press of Harvard University Press.
17. Conner, K.R. (1991) 'A Historical Comparison of Resource-Based Theory and Five Schools of Thought within Industrial Organization Economics: Do We Have a New Theory of the Firm?', Journal of Management 17: 121-54.
18. Dalum, B. (1992) 'Export Specialisation, Structural Competitiveness and National Systems of Innovation', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 191-225. London: Pinter.
19. Drews, J. (1999) In Quest of Tomorrow's Medicines. New York: Springer Verlag.
20. Drews, J. (2000) 'Drug Discovery: A Historical Perspective', Science 287: 1960-4.
21. EMEA (European Medicines Agency) (2006) About the EMEA, URL: www.emea.eu.int/htms/aboutus/emeaoverview.htm
22. Ernst & Young (2003) Endurance - The European Biotechnology Report 2003: 10th Anniversary Edition. London ; Ernst & Young Llp.
23. Ernst & Young (2005) Kräfte der Evolution: Deutscher Biotechnologie-Report 2005. Mannheim: Ernst & Young Ag Wirtschaftsprüfungsgesellschaft.
24. Ernst & Young (2006) Zurück in die Zukunft: Deutscher Biotechnologie-Report 2006. Mannheim: Ernst & Young Ag Wirtschaftsprüfungsgesellschaft.
25. Estevez-Abe, M., Iversen, T. and Soskice, D.W. (2001) 'Social Protection and the Formation of Skills: A Reinterpretation of the Welfare State', in P. A. Hall and D. W. Soskice (eds) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage, pp. 145-83. Oxford: Oxford University Press.
26. Fagerberg, J. (1992) 'The Home Market Hypothesis Re-Examined: The Impact of Domestic User-Producer Interaction on Export Specialisation', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 226-41. London: Pinter.
27. Feige, E.L. and Watts, H.W. (1972) 'An Investigation of the Consequences of Partial Aggregation of Micro-Economic Data', Econometrica 40: 343-60.
28. Freeman, C. (1992) 'Formal Scientific and Technical Institutions in the National System of Innovation', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 169-87. London: Pinter.
29. Freyberg, M. (2004) 'Telephone Interview with Mark Freyberg (CEO of Cytotools GMBH)', Darmstadt, 23 April.
30. Gambardella, A., Orsenigo, L. and Pammolli, F. (2001) Global Competitiveness in Pharmaceuticals: A European Perspective. Luxembourg: Office for Official Publications of the European Communities.
31. Grant, R.M. (1998) Contemporary Strategy Analysis. Malden, MA: Blackwell.
32. Hall, P.A. and Soskice, D.W. (2001 a) 'An Introduction to Varieties of Capitalism', in P. A. Hall and D. W. Soskice (eds) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage, pp. 1-68. Oxford: Oxford University Press.
33. Hall, P. A. and Soskice, D. W. (eds) (2001 b) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage. Oxford: Oxford University Press.
34. Hancké, B. and Herrmann, A.M. (2007) 'Wage Bargaining and Comparative Advantage in EMU', in B. Hancké, M. Rhodes and M. Thatcher (eds) Beyond Varieties of Capitalism, pp. 122-44. Oxford: Oxford University Press.
35. Hancké, B., Rhodes, M. and Thatcher, M. (eds) (2007) Beyond Varieties of Capitalism. Oxford: Oxford University Press.
36. Heckscher, E.F. (1919) 'The Effect of Foreign Trade on the Distribution of Income', in H. Flam and J. M. Flanders (eds) Heckscher-Ohlin Trade Theory, pp. 43-69. Cambridge, MA: The MIT Press.
37. Hinze, S., Reiβ, T., Dominguez-Lacasa, I. and Wörner, S. (2001) Einfluss der Biotechnologie auf das Innovationssystem der Pharmazeutischen Industrie. Karlsruhe: Fraunhofer Institut Für Systemtechnik.
38. Hollingsworth, R.J. (2000) 'Doing Institutional Analysis: Implications for the Study of Innovations', Review of International Political Economy 7: 595-644.
39. Keck, O. (1993) 'The National System for Technical Innovation in Germany', in R. R. Nelson (ed.) National Innovation Systems: A Comparative Analysis, pp. 115-57. Oxford: Oxford University Press.
40. King, D. and Wood, S. (1999) 'The Political Economy of Neoliberalism: Britain and the United States in the 1980s', in H. Kitschelt, P. Lange, G. Marks and J. D. Stephens (eds) Continuity and Change in Contemporary Capitalism, pp. 371-97. Cambridge: Cambridge University Press.
41. Kogut, B. (1985) 'Designing Global Strategies: Comparative and Competitive Value-Added Chains', Sloan Management Review 26: 15-28.
42. Läsker, K. (2005) 'Der Einstieg Der Ausländer', Süddeutsche Zeitung 29 January: 22.
43. Lindbeck, A. and Snower, D.J. (2001) 'Centralized Bargaining and Reorganized Work: Are They Compatible?', European Economic Review 45: 1851-75.
44. Lindgaard Christensen, J. (1992) 'The Role of Finance in National Systems of Innovation', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 146-68. London: Pinter.
45. Lundvall, B.-A. (1992 a) 'Introduction', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 1-19. London: Pinter.
46. Lundvall, B.-A. (1992 b) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning. London: Pinter.
47. Lundvall, B.-A. (1992 c) 'User-Producer Relationships, National Systems of Innovation and Internationalisation', in B.-A. Lundvall (ed.) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, pp. 45-67. London: Pinter.
48. Lundvall, B.-Å. and Maskell, P. (2000) 'Nation States and Economic Development: From National Systems of Production to National Systems of Knowledge Creation and Learning', in G. L. Clark, M. P. Feldman and M. S. Gertler (eds) The Oxford Handbook of Economic Geography, pp. 353-7.Oxford: Oxford University Press.
49. Malerba, F. (1993) 'The National System of Innovation: Italy', in R. R. Nelson (ed.) National Innovation Systems: A Comparative Analysis, pp. 230-8. Oxford: Oxford University Press.
50. Muffatto, M. and Giardina, G. (2003) 'Innovazioni nei Processi di Ricerca in Campo Farmaceutico', Economia and Management 6: 107-21.
51. Nelson, R.R. (1993) National Innovation Systems: A Comparative Analysis. Oxford: Oxford University Press.
52. Newbert, S.L. (2007) 'Empirical Research on the Resource-Based View of the Firm: An Assessment and Suggestions for Future Research', Strategic Management Journal 28: 121-46.
53. Ohlin, B. (1924) 'The Theory of Trade', in H. Flam and J. M. Flanders (eds) Heckscher-Ohlin Trade Theory, pp. 71-214. Cambridge, MA: The MIT Press.
54. Ohlin, B. (1933) Interregional and International Trade. Cambridge, MA: Harvard University Press.
55. Orsenigo, L., Pammolli, F. and Riccaboni, M. (2001) 'Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry', Research Policy 30: 485-508.
56. Owen-Smith, J., Riccaboni, M., Pammolli, F. and Powell, W.W. (2002) 'A Comparison of US and European University-Industry Relations in the Life Sciences', Management Science 48: 24-43.
57. Pammolli, F., Magazzini, L. and Orsenigo, L. (2002) 'The Intensity of Competition after Patent Expiry in Pharmaceuticals: A Cross-Country Analysis', Revue D'Économie Industrielle 99: 107-31.
58. Patel, P. and Pavitt, K. (1994) 'National Innovation Systems: Why They are Important, and How They Might be Measured and Compared', Economics of Innovation and New Technology 3: 77-95.
59. Pavitt, K. and Patel, P. (1999) 'Global Corporations and National Systems of Innovation: Who Dominates Whom?', in D. Archibugi, J. Howells and J. Michie (eds) Innovation Policy in a Global Economy, pp. 94-119. Cambridge: Cambridge University Press.
60. Peteraf, M.A. (1993) 'The Cornerstones of Competitive Advantage: A Resource-Based View', Strategic Management Journal 14: 179-91.
61. Porter, M.E. (1980) Competitive Strategy: Techniques for Analyzing Industries and Competitors. London and New York: The Free Press.
62. Porter, M.E. (1985) Competitive Advantage: Creating and Sustaining Superior Performance. New York: The Free Press.
63. Porter, M.E. (1987) 'Changing Patterns of International Competition', in D. J. Teece (ed.) The Competitive Challenge, pp. 27-57. New York: Harper and Row.
64. Porter, M.E. (1990) The Competitive Advantage of Nations. London: Macmillan.
65. Pozzali, A. (2004) 'La Situazione Italiana e Lombarda nel Settore Biotecnologico', in D. Diamantini (ed.) Il Manager Dell'innovazione. Milan: Guerini.
66. Robinson, W.S. (1950) 'Ecological Correlations and the Behavior of Individuals', American Sociological Review 15: 351-7.
67. Rumelt, R.P. (1984) 'Toward a Strategic Theory of the Firm', in R. B. Lamb (ed.) Competitive Strategic Management, pp. 556-70. Englewood Cliffs, NJ: Prentice-Hall.
68. Rumelt, R.P. (1991) 'How Much Does Industry Matter?', Strategic Management Journal 12: 167-85.
69. Schröder, A. (2004) 'Nachahmer gelten als Fusionskandidaten', Stuttgarter Zeitung 31 January: 17.
70. Sinn, H.-W. (2005) Die Basar-konomie; Deutschland: Exportweltmeister Oder Schlusslicht? Berlin: Econ Verlag.
71. Streeck, W. (1991) 'On the Institutional Conditions of Diversified Quality Production', in E. Matzner and W. Streeck (eds) Beyond Keynesianism: The Socio-Economics of Production and Full Employment, pp. 21-61. Aldershot: Edward Elgar.
72. Streeck, W. and Thelen, K. (2005) 'Introduction: Institutional Change in Advanced Political Economies', in Streeck, W. and Thelen, K. (eds) Beyond Continuity: Institutional Change in Advanced Political Economies, pp. 1-39. Oxford: Oxford University Press.
73. Teece, D.J., Pisano, G. and Shuen, A. (1997) 'Dynamic Capabilities and Strategic Management', Strategic Management Journal 18: 509-33.
74. Thomas III, L.G. (2004) 'Are We All Global Now? Local vs Foreign Sources of Corporate Competence: The Case of the Japanese Pharmaceutical Industry', Strategic Management Journal 25: 865-86.
75. Thomson Financial (2004) Venturexpert, URL: www.venturexpert.com, retrieved 19 October.
76. Trento, S. (2005) 'Corporate Governance and Industrial Relations in Italy', in H. Gospel and A. Pendleton (eds) Corporate Governance and Labour Management: An International Comparison, pp. 226-53. Oxford: Oxford University Press.
77. Vingiani, L. (2006) 'Interview with Dr Leonardo Vingiani (director of Assobiotec: Associazione Nazionale Per Lo Sviluppo Delle Biotecnologie)', Milan, 16 January.
78. Vitols, S. (2001) 'Varieties of Corporate Governance: Comparing Germany and the UK', in P. A. Hall and D. W. Soskice (eds) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage. Oxford: Oxford University Press.
79. Walker, G. (2003) Modern Competitive Strategy. New York: McGraw-Hill.
80. Walker, W. (1993) 'National Innovation Systems: Britain', in R. R. Nelson (ed.) National Innovation Systems: A Comparative Analysis, pp. 158-91. Oxford: Oxford University Press.
81. Wernerfelt, B. (1984) 'A Resource-Based View of the Firm', Strategic Management Journal 5: 171-80.
82. Wittner, P. (2003) The European Generics Outlook: A Country-by-Country Analysis of Developing Market Opportunities and Revenue Defense Strategies. London: Datamonitor.
83. Wittner, P. (2005) An Exploration of Consolidation in the Generics Industry. Waltham, MA: Decision Resources.